Kim L. Mercer
- Oncology top 2%
- Cancer-related Molecular Pathways 5
- Lung Cancer Research Studies 2
- Cancer Research top 2%
- Molecular Biology top 2%
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
- PI3K/AKT/mTOR signaling in cancer 2
- Aging top 5%
- Biotechnology top 5%
-
- Immunotherapy and Immune Responses 2
-
- Virus-based gene therapy research 1
-
- Cancer Mechanisms and Therapy 1
Kim L. Mercer
15 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 1.6k
- Cancer Research 737
- Molecular Biology 2.6k
- Aging 57
- Biotechnology 183
Countries citing papers authored by Kim L. Mercer
This map shows the geographic impact of Kim L. Mercer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim L. Mercer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim L. Mercer more than expected).
Fields of papers citing papers by Kim L. Mercer
This network shows the impact of papers produced by Kim L. Mercer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim L. Mercer. The network helps show where Kim L. Mercer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kim L. Mercer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2020 | 7 | |
| 3 | 2020 | 42 | |
| 4 | 2020 | 8 | |
| 5 | 2019 | 58 | |
| 6 | 2019 | 103 | |
| 7 | 2013 | 93 | |
| 8 | 2010 | 7 | |
| 9 | 2009 | 1 | |
| 10 | Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defectsbreakdown → | 2004 | 626 |
| 11 | 2003 | 129 | |
| 12 | 2002 | 35 | |
| 13 | Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasbreakdown → | 2001 | 1392 |
| 14 | Somatic activation of the K-ras oncogene causes early onset lung cancer in micebreakdown → | 2001 | 906 |
| 15 | 1997 | 449 |
About Kim L. Mercer
Kim L. Mercer is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 15 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (2 papers), Lung Cancer Research Studies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Immunotherapy and Immune Responses (2 papers), Virus-based gene therapy research (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (737 citations) and Molecular Biology (2.6k citations). Kim L. Mercer has collaborated with scholars based in United States and Germany. Frequent co-authors include Tyler Jacks, Roderick T. Bronson, Denise Crowley, David A. Tuveson, Nicholas A. Willis, Erica L. Jackson, R Montoya, Doron C. Greenbaum, Leisa Johnson and Sunil R. Hingorani. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.